Pharmaceutical companies operate in one of the most heavily regulated industries in the world. From early product development to post-market surveillance, each step demands strict compliance with a complex web of global regulations. A Regulatory Management System (RMS) helps make that compliance manageable. Far more than a digital filing cabinet, an RMS is a centralized,
Tag Archives: compliance
SANTA CLARA, Calif., April 1, 2025—ValGenesis, Inc. ValGenesis Inc., a leading provider of enterprise validation lifecycle management solutions, announced that Scigeniq has successfully implemented ValGenesis VLMS 5.0, modernizing its qualification and validation processes. As a life sciences technology and consulting firm specializing in compliance solutions, Scigeniq adopted VLMS to streamline internal processes and strengthen its
For young pharmaceutical companies, the prospect of an audit — whether internal or from regulators — can be intimidating. And it is not just the worries about the audit results; it is the large amount of preparation needed to get ready. Pulling together the proper documents, double-checking training records, and making sure every deviation is
For growing life sciences companies, investing in technology is a critical key to unlocking rapid growth. But the question of where to start can be perplexing. One great choice is to address the need to plan and manage employee training activities. Selecting the right Training Management System (TMS) can immediately address regulatory requirements while improving
Brazil represents one of the largest pharmaceutical markets in the world, ranking among the top ten globally and leading the Latin American region. Over the past decade, the sector has witnessed steady growth, driven by increasing healthcare investments, rising disposable incomes, and a growing middle class. As the world’s sixth-most populous country, Brazil offers a
The pharmaceutical landscape in the Middle East and North Africa (MENA) region is undergoing a rapid transformation, and Saudi Arabia is firmly at its helm. With its proactive regulatory framework, ambitious Vision 2030 objectives, and substantial investment in local production, the Kingdom is shaping the future of the region’s pharma industry. Smart pharmaceutical companies and
For young pharma companies, the focus is typically on research, securing funding, and pushing products through the development pipeline. However, the need for a more structured, automated Quality Management System (QMS) becomes critical as operations grow. At that point, moving from manual processes to an automated QMS is not just a “nice to have”—it is
It is just a guess, but over the last 25 years, I have probably helped about 100 companies transition from paper-based systems to automated systems for managing documents, quality processes, and training activities. One thing I have learned is that for some companies, the transition is fast and relatively painless, and for others, it can
Navigating the complex regulatory environment is a constant challenge in every country. Between evolving standards, stringent documentation requirements, and the need for timely submissions, keeping up can overwhelm even the most efficient teams. Nowhere is this more true than in Brazil, where ensuring compliance with ANVISA (Agência Nacional de Vigilância Sanitária) requires constant attention and
For fast-growing pharma companies, managing assets effectively is crucial for maintaining compliance, ensuring quality, and optimizing operations. An Asset Management System (AMS) can play a central role in this effort, offering a structured approach to tracking and maintaining the physical and digital assets vital to research, development, and production. Why Invest in an Asset Management
- 1
- 2